IPHA

Innate Pharma
IPHA

18 hedge funds and large institutions have $5.82M invested in Innate Pharma in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.16M
2
+$1.07M
3
+$771K
4
VF
Virtu Financial
New York
+$676K
5
Optiver Holding
Optiver Holding
Netherlands
+$645K

Top Sellers

1
-$121K
2
-$116K
3
-$900
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.16M
2
$1.07M
3
$771K
4
$676K
5
$673K
6
$509K
7
$167K
8
$151K
9
$124K
10
$116K
11
$114K
12
$109K
13
$106K
14
$44K
15
$12K
16
$6K
17
$6K
18
$3K